Results 1 to 10 of about 8,494 (119)

The role of timely rheumatoid arthritis treatment effectiveness control

Consilium Medicum, 2023
Background. Regular assessment of rheumatoid arthritis (RA) activity is a key factor in therapy effectiveness improving. Aim. To prove that timely RA treatment control recommended by modern guidelines improves outcomes and reduce disability in real ...
Larisa M. Musaeva, Yulia A. Prokofeva, Irina V. Menshikova, Aishat E. Rasulova   +3 more
doaj   +1 more source

Association between the Composite Dietary Antioxidant Index and Atherosclerotic Cardiovascular Disease in Postmenopausal Women: A Cross-Sectional Study of NHANES Data, 2013–2018

Antioxidants, 2023
The relationship between composite dietary antioxidant index (CDAI) levels and the risk of atherosclerotic cardiovascular disease (ASCVD) in postmenopausal women is unknown.
Chenning Liu, Wenyu Lai, Meiduo Zhao, Yexuan Zhang, Yuanjia Hu   +4 more
doaj   +1 more source

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis

Научно-практическая ревматология, 2012
Objective: to evaluate the clinical efficiency of tocilizumab (TCZ) versus rituximab (RTM) therapy using DAS 28, SDAI, and CDAI scores and to estimate remission rates using DAS 28 and the remission criteria proposed by the European League Against ...
Anastasia Sergeyevna Avdeyeva, E N Aleksandrova, E Yu Panasyuk, G V Lukina, E L Nasonov   +4 more
doaj   +1 more source

Composite dietary antioxidant index was negatively associated with the prevalence of diabetes independent of cardiovascular diseases

Diabetology & Metabolic Syndrome, 2023
Aim The association between composite dietary antioxidant index (CDAI) and diabetes remains unknown. Our study was to investigate the association of CDAI with diabetes.
Xiaojie Chen, He Lu, Yingwei Chen, Haiqiang Sang, Yi Tang, Yifan Zhao   +5 more
doaj   +1 more source

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis

Научно-практическая ревматология, 2012
Objective: to evaluate the impact of tocilizumab (TCZ) therapy on the level of acute-phase indicators, autoantibodies, and immunoglobulins (Ig) G, M, and A after 2, 4, 8, 12, and 24 weeks as compared to the clinical efficacy of TCZ using DAS 28, SDAI ...
Anastasia Sergeyevna Avdeyeva, E N Aleksandrova, E Yu Panasyuk, A A Novikov, M V Cherkasova, E L Nasonov   +5 more
doaj   +1 more source

IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS

Научно-практическая ревматология, 2012
Objective — to evaluate the impact of tocilizumab (TCZ) therapy on progression of joint destruction and rheumatoid arthritis (RA) inflammatory activity in 48 weeks after initiation of treatment. Material and methods.
Anastasia Sergeevna Avdeeva, A V Smirnov, E Yu Panasyuk, E N Alexandrova, E L Nasonov   +4 more
doaj   +1 more source

EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)

Научно-практическая ревматология, 2014
Objective. To evaluate the effectiveness and tolerance of Etanercept (ETN) therapy in patients with rheumatoid arthritis (RA).Material and Methods. 188 adult patients with severe and moderate RA (average DAS28 score of 6.26±0.89) subcutaneously received ...
Anna Olegovna Pchelintseva, E Yu Panasyuk, O F Ryabitseva, V I Mazurov, I G Salikhov, A E Sizikov, O N Ivanova, V N Sorotskaya, O V Semagina, I V Vinogradova, A I Kulikov, L N Denisov, E L Nasonov   +12 more
doaj   +1 more source

Evaluation of the clinical efficiency of tocilizumab therapy, by using DAS 28, SDAI, CDAI indices and new 2011 EULAR/ACR remission criteria in patients with rheumatoid arthritis

Научно-практическая ревматология, 2012
Objective: to evaluate the clinical efficiency of tocilizumab (TCZ) from the DAS 28, SDAI, and CDAI indices and to estimate remission rates from the European League Against Rheumatism (EULAR) criteria, and the new remission criteria proposed by the EULAR
Anastasia Sergeyevna Avdeyeva, E Yu Panasyuk, E N Aleksandrova, E L Nasonov   +3 more
doaj   +1 more source

Patterns of Response to Different Treatment Strategies in Seropositive Rheumatoid Arthritis Patients in a Tertiary Hospital in South‐Western Saudi Arabia: A Retrospective Study

Open Access Rheumatology: Research and Reviews, 2021
Mohammed AlOmair,* Hanan AlMalki,* Nouf AlShamrani, Ghadah Habtar, Maram AlAsmari, Wejdan Mobasher, Hanan AlQahtani, Aydah Rahman, Alhussain Asiri Division of Rheumatology, Department of Medicine, Aseer Central Hospital, Abha, Saudi Arabia&ast ...
AlOmair M, AlMalki H, AlShamrani N, Habtar G, AlAsmari M, Mobasher W, AlQahtani H, Rahman A, Asiri A   +8 more
doaj  

Association between composite dietary antioxidant index and coronary heart disease among US adults: a cross-sectional analysis

BMC Public Health, 2023
Background The Composite Dietary Antioxidant Index (CDAI) is a dietary antioxidant score that plays a protective role in many diseases, including depression, osteoporosis, papillomavirus infection, etc.
Ruicong Ma, Xinyang Zhou, Guolin Zhang, Hongying Wu, Yi Lu, Fengyi Liu, Yeting Chang, Yanchun Ding   +7 more
doaj   +1 more source